HF
TMO icon

HRT Financial’s Thermo Fisher Scientific TMO Stock Holding History

HRT Financial’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-700
Closed -$406K – 3107
2024
Q1 		$406K Sell
700
-200
-22% -$112K ﹤0.01% 1373
2023
Q4 		$477K Buy
+900
New +$436K ﹤0.01% 1398

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HRT Financial's TMO Position: Q1 2026 in Review

HRT Financial opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 554 shares worth $272K. The stake represents ﹤0.01% of the portfolio and ranks #2955 among its holdings. This is a return to the name: HRT Financial previously reported a position in TMO as recently as Q3 2025.

HRT Financial first reported a position in TMO in Q3 2019 and has held it in 16 quarters since. The position peaked at $86.2M in Q2 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • HRT Financial held 554 shares of Thermo Fisher Scientific worth $272K as of Q1 2026.
  • Thermo Fisher Scientific was a new HRT Financial position in Q1 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2955 holding.
  • HRT Financial first reported a position in Thermo Fisher Scientific in Q3 2019 and has held it in 16 quarters since.
  • HRT Financial's Thermo Fisher Scientific position peaked at $86.2M in Q2 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.